Bone Marrow TransplantationTransplantation, HomologousLeukemia, Myeloid, AcuteBone MarrowLeukemia, MyeloidGraft vs Host DiseaseHematopoietic Stem Cell TransplantationBone Marrow CellsTransplantation, AutologousLeukemiaTransplantation ConditioningLiver TransplantationWhole-Body IrradiationTransplantation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveAcute DiseaseTissue DonorsGraft SurvivalRemission InductionBusulfanRecurrenceTreatment OutcomeStem Cell TransplantationMyelodysplastic SyndromesKidney TransplantationTransplantation, IsogeneicHistocompatibility TestingHematologic NeoplasmsHematopoietic Stem CellsPrecursor Cell Lymphoblastic Leukemia-LymphomaAnemia, AplasticBone and BonesCytarabineHistocompatibilitySurvival AnalysisImmunosuppressive AgentsGraft RejectionCyclophosphamideTransplantation ImmunologyBone Marrow PurgingCombined Modality TherapyHeart TransplantationGraft vs Tumor EffectTime FactorsSurvival RateAntineoplastic Combined Chemotherapy ProtocolsRetrospective Studiesfms-Like Tyrosine Kinase 3Graft vs Leukemia EffectDisease-Free SurvivalHematopoiesisMice, Inbred C57BLGene Expression Regulation, LeukemicLung TransplantationLymphocyte DepletionLeukemia, Myelomonocytic, AcutePrognosisGranulocyte Colony-Stimulating FactorPeripheral Blood Stem Cell TransplantationAntigens, CD34ImmunosuppressionT-LymphocytesBone Marrow DiseasesHepatic Veno-Occlusive DiseaseDaunorubicinCyclosporineNeoplasm, ResidualHLA AntigensMultiple MyelomaBone Marrow ExaminationLymphoma, Non-HodgkinRadiation ChimeraLymphocyte TransfusionVidarabineOrgan TransplantationAntineoplastic AgentsFollow-Up StudiesHematopoietic Stem Cell MobilizationCord Blood Stem Cell TransplantationNuclear FamilyImmunophenotypingLeukemia, Lymphocytic, Chronic, B-CellCytogeneticsCell DifferentiationKaryotypingGraft vs Host ReactionMelphalanLeukemia, LymphoidLeukocyte TransfusionFlow CytometryBlast CrisisMyeloablative AgonistsSalvage TherapyIdarubicinLymphomaLeukemia, ExperimentalCytogenetic AnalysisEtoposideColony-Forming Units AssayActuarial Analysis